Bright Minds Biosciences Inc.

General ticker "DRUG" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $216.5M (TTM average)

Bright Minds Biosciences Inc. follows the US Stock Market performance with the rate: 49.3%.

Estimated limits based on current volatility of 2.7%: low 86.62$, high 91.37$

Factors to consider:

  • Total employees count: 2 as of 2022
  • Current price 4138.5% above estimated high
  • Earnings for 12 months up through Q4 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-09-30 to 2026-09-30

  • 2024-09-30 to 2025-09-30 estimated range: [0.80$, 2.19$]
  • 2025-09-30 to 2026-09-30 estimated range: [0.76$, 2.08$]

Financial Metrics affecting the DRUG estimates:

  • Positive: with PPE of -2.4 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -26.04 <= 0.04
  • Positive: Shareholder equity ratio, % of 90.69 > 64.17
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Investing cash flow per share per price, % of 0 > -0.62
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: negative Industry operating cash flow (median)

Similar symbols

Short-term DRUG quotes

Long-term DRUG plot with estimates

Financial data

YTD 2023-09-30 2024-09-30
Operating Revenue CA$0.00MM CA$0.00MM
Operating Expenses CA$7.20MM CA$2.62MM
Operating Income CA$-7.20MM CA$-2.62MM
Non-Operating Income CA$-0.17MM CA$-0.19MM
R&D Expense CA$5.00MM CA$1.18MM
Income(Loss) CA$-7.37MM CA$-2.80MM
Profit(Loss)* CA$-7.37MM CA$-2.80MM
Stockholders Equity CA$6.60MM CA$5.54MM
Assets CA$6.88MM CA$6.10MM
Operating Cash Flow CA$-7.02MM CA$-1.85MM
Capital expenditure CA$0.00MM CA$0.00MM
Financing Cash Flow CA$2.19MM CA$0.81MM
Earnings Per Share** CA$-1.98 CA$-0.65

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.